Loading...

PolarityTE, Inc.

PTENASDAQ
HealthcareBiotechnology
$0.24
$-0.00(-0.82%)

PolarityTE, Inc. (PTE) Stock Overview

Explore PolarityTE, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for PTEStats details for PTE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for PTEAnalyst Recommendations details for PTE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

CEO

Mr. Richard Hague

Employees

42

Headquarters

1960 South 4250 West, Salt Lake City, UT

Founded

1999

Frequently Asked Questions